Cat. No.: DMM-001271
Status | Age | Sex |
---|---|---|
|
|
|
Model Overview | |
---|---|
Model Description | These RIPHAT transgenic mice express human islet amyloid polypeptide (h-IAPP) under the regulatory control of the rat insulin II promoter and may be useful in studying the beta-cell destruction and islet amyloid deposition associated with non-insulin-dependent diabetes mellitus (NIDDM) or Type II diabetes, as well as beta-cell apoptosis and characteristics of the endoplasmic reticulum (ER) stress pathway. |
Strain Name | FVB/N-Tg(Ins2-IAPP)RHFSoel/J |
Background Strain | FVB/N |
SPF | Yes |
Research Application | Diabetes |
Target Information | |
---|---|
Target Name | Tg(Ins2-IAPP)RHFSoel |
Synonyms | RIPHAT,RIPHAT line RHF,Tg(IAPP)6Jdm |
Gene ID | - |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.